CIANCIUSI, ANNARITA

CIANCIUSI, ANNARITA  

100019 - Dipartimento di chimica e chimica industriale  

Mostra records
Risultati 1 - 12 di 12 (tempo di esecuzione: 0.017 secondi).
Titolo Data di pubblicazione Autore(i) File
4,6-Diphenyl-pyridines/pyrimidines and pyrazolo[3,4-d]pyrimidines: promising scaffolds as antiviral, anticancer and theranostic agents. 29-mar-2023 Cianciusi, Annarita
Development of a new potential theranostic prodrug for targeting glioblastoma multiforme 1-gen-2022 Carbone, A.; D’Agostino, I.; Cianciusi, A.; Musumeci, F.; Salis, A.; D’Antona, L.; Petroni, D.; Dreassi, E.; Menichetti, L.; Schenone, S.
Early investigation of a novel SI306 theranostic prodrug for glioblastoma treatment 1-gen-2024 Vagaggini, Chiara; Petroni, Debora; D'Agostino, Ilaria; Poggialini, Federica; Cavallini, Chiara; Cianciusi, Annarita; Salis, Annalisa; D'Antona, Lucia; Francesconi, Valeria; Manetti, Fabrizio; Damonte, Gianluca; Musumeci, Francesca; Menichetti, Luca; Dreassi, Elena; Carbone, Anna; Schenone, Silvia
Identification and Biological Characterization of the Pyrazolo[3,4-d]pyrimidine Derivative SI388 Active as Src Inhibitor 1-gen-2023 Contadini, Claudia; Cirotti, Claudia; Carbone, Anna; Norouzi, Mehrdad; Cianciusi, Annarita; Crespan, Emmanuele; Perini, Cecilia; Maga, Giovanni; Barilà, Daniela; Musumeci, Francesca; Schenone, Silvia
New potential anti-flu agents acting by disrupting the PA-PB1 interaction of viral polymerase. 1-gen-2021 Cianciusi, A.; Musumeci, F.; D’Agostino, I.; Schenone, S.
Novel pyrazolo[3,4-d]pyrimidines as dual Src/Bcr-Abl kinase inhibitors: Synthesis and biological evaluation for chronic myeloid leukemia treatment 1-gen-2022 Di Maria, Salvatore; Picarazzi, Francesca; Mori, Mattia; Cianciusi, Annarita; Carbone, Anna; Crespan, Emmanuele; Perini, Cecilia; Sabetta, Samantha; Deplano, Serenella; Poggialini, Federica; Molinari, Alessio; Aronne, Rossella; Maccioni, Elias; Maga, Giovanni; Angelucci, Adriano; Schenone, Silvia; Musumeci, Francesca; Dreassi, Elena
Si113-prodrugs selectively activated by plasmin against hepatocellular and ovarian carcinoma 1-gen-2021 Rango, E.; D'Antona, L.; Iovenitti, G.; Brai, A.; Mancini, A.; Zamperini, C.; Trivisani, C. I.; Marianelli, S.; Fallacara, A. L.; Molinari, A.; Cianciusi, A.; Schenone, S.; Perrotti, N.; Dreassi, E.; Botta, M.
SYNTHESIS AND BIOLOGICAL EVALUATION OF NEW 4-AMINO-PYRAZOLO[3,4-d]PYRIMIDINES AS POTENTIAL SRC KINASE INHIBITORS 1-gen-2023 Falesiedi, M.; Cianciusi, A.; Carbone, A.; Musumeci, F.; Schenone, S.; Angelucci, A.; Sabetta, S.; Maga, G.; Crespan, E.
Synthesis of a new generation of potential anti-influenza agents targeting the PA-PB1 protein-protein interaction. 1-gen-2021 Cianciusi, A.; Schenone, S.; Musumeci, F.; D’Agostino, I.
Synthesis of a new series of optimized pyrazolo[3,4‑d]pyrimidines as Src Inhibitors 1-gen-2021 Cianciusi, Annarita; Carbone, Anna; Musumeci, Francesca; Schenone, Silvia
Synthesis of hybrid small molecules as potential PA-PB1 heterodimer disruptors of Influenza virus Polymerase 1-gen-2021 Cianciusi, A.; Musumeci, F.; Carbone, A.; D’Agostino, I.; Schenone, S.
Synthetic Heterocyclic Derivatives as Kinase Inhibitors Tested for the Treatment of Neuroblastoma 1-gen-2021 Musumeci, Francesca; Cianciusi, Annarita; D’Agostino, Ilaria; Grossi, Giancarlo; Carbone, Anna; Schenone, Silvia